Dorte Renneberg,Francis Hubler,Jacques-Alexis Funel,Katharina Reichenbaecher,Kurt Hilpert,Markus Von Raumer,Stefan Abele,Stephanie Combes
申请号：
BRPI0920635
公开号：
BRPI0920635A2
申请日:
2009.10.21
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
The invention relates to crystalline salts of isobutyric acid (1R*,2R*,4R*)-2-(2-{[3-(4,7 -dimethoxy-1H-benzoimidazol-2-yl)-propyl]-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester, processes for the preparation thereof, pharmaceutical compositions containing said crystalline salts, and their use as medicaments, especially as calcium channel blockers.
